Filovirus vaccines: what challenges are left?

被引：4
|
作者：
Bukreyev, Alexander [1 ]
Collins, Peter L. [1 ]
机构：
[1] NIAID, RNA Viruses Sect, Infect Dis Lab, NIH, Bethesda, MD 20892 USA
来源：
EXPERT REVIEW OF VACCINES | 2010年 / 9卷 / 01期
关键词：
PROTECTS NONHUMAN-PRIMATES; STOMATITIS-VIRUS VECTORS; EBOLA HEMORRHAGIC-FEVER; MARBURG VIRUS; POSTEXPOSURE PROTECTION; RHESUS-MONKEYS; GUINEA-PIGS; INFECTION; IMMUNITY; TRANSMISSION;
D O I：
10.1586/ERV.09.150
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：5 / 8
页数：4
相关论文
共 50 条
  • [41] COVID-19: Prospective Challenges and Potential Vaccines
    Nadeem, Muhammad Shahid
    Ali, Akbar
    Al-Ghamdi, Maryam A.
    Depfenhart, Markus
    Khan, Jalaluddin Azam
    Zamzami, Mazin A.
    Murtaza, Bibi Nazia
    Kazmi, Imran
    Rehman, Mujadid Ur
    ALTERNATIVE THERAPIES IN HEALTH AND MEDICINE, 2020, 26 : 72 - 78
  • [42] SARS-CoV-2: Immunity, Challenges with Current Vaccines, and a Novel Perspective on Mucosal Vaccines
    Sunagar, Raju
    Singh, Amit
    Kumar, Sudeep
    VACCINES, 2023, 11 (04)
  • [43] Challenges of HIV therapeutic vaccines clinical trials design
    Bailon, Lucia
    Alarcon-Soto, Yovaninna
    Benet, Susana
    CURRENT OPINION IN HIV AND AIDS, 2022, 17 (06) : 345 - 351
  • [44] Overview of multistage subunit tuberculosis vaccines: advantages and challenges
    Keikha, Masoud
    Eslami, Majid
    Yousefi, Bahman
    Karbalaei, Mohsen
    REVIEWS IN MEDICAL MICROBIOLOGY, 2020, 31 (03) : 144 - 149
  • [45] COVID-19 vaccines: current and future challenges
    Mohammadi, Davood
    Ghasemi, Matin
    Manouchehrian, Nahid
    Zafarmand, Milad
    Akbari, Mitra
    Boroumand, Amir Bahador
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [46] Tfh cell response in influenza vaccines in humans: what is visible and what is invisible
    Ueno, Hideki
    CURRENT OPINION IN IMMUNOLOGY, 2019, 59 : 9 - 14
  • [47] What's Old and New in Tuberculosis Vaccines for Children
    Cranmer, Lisa M.
    Cotton, Mark F.
    Day, Cheryl L.
    Nemes, Elisa
    JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2022, 11 (SUPP 3) : S110 - S116
  • [48] The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What
    Khong, Ka-Wa
    Zhang, Ruiqi
    Hung, Ivan Fan-Ngai
    VACCINES, 2022, 10 (11)
  • [49] So we now have RSV vaccines. What's our next steps?
    Blondeau, Joseph M.
    EXPERT REVIEW OF RESPIRATORY MEDICINE, 2024, 18 (1-2) : 17 - 22
  • [50] Challenges and advancements in the development of vaccines and therapies against Chagas disease
    Pinazo, Maria Jesus
    Malchiodi, Emilio
    Ioset, Jean-Robert
    Bivona, Augusto
    Gollob, Kenneth J.
    Dutra, Walderez O.
    LANCET MICROBE, 2024, 5 (10):
12345